Matt Hervey is a patent litigator in Gowling WLG's award-winning international IP team. His multi-jurisdictional technology patent litigation experience includes SEP disputes involving communications (2G, 3G, LTE, DSL and others standards) and video compression, along with cases concerning software (algorithmic trading, consumer share trading platforms and 3D modelling), consumer electronics (inkjet printers), location sensing, traffic analysis and aircraft design.
Hervey also has extensive experience of Life Sciences and healthcare disputes, including monoclonal antibodies, biosimilars, toxins, medical devices and cosmetics. He managed the team that successfully defended three patents of the Kennedy Trust for Rheumatology Research in the first 'biosimilar' patent litigation in the UK and ran one of the cases for Fujifim Kyowa Kirin Biologics Co., Ltd leading to the first granted "Arrow" (or "Fujifilm") declaration in the UK.
Hervey also has experience of high-value arbitration.
Hervey is a regular speaker on patents and technology in the US and around Europe. He has spoken this year on artificial intelligent, autonomous vehicles, disruptive technologies and the law, blockchain and cybersecurity.